Osphos is a drug owned by DECHRA, LTD. It is protected by 1 US drug patent filed in 2026. All patents are active. Details of Osphos’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US7781420 | Active | |
Exclusivity Information
Osphos holds 1 exclusivity out of which 1 has expired. Details of Osphos's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | Apr 28, 2019 |
About Osphos
Osphos is a drug
owned by DECHRA, LTD.
Osphos uses
Clodronate as the active
ingredient.
Active Ingredient:
Osphos uses
Clodronate as the active ingredient.
Check out other Drugs and Companies using
Clodronate ingredient.